Skip to main content
Also available in 1 other language

简体中文

Beginner 3 min read

Types of Lung Cancer: Small vs. Non-Small Cell

A plain-language explanation of the two main types of lung cancer — non-small cell and small cell — and how they differ. Based on the American Cancer Society.

Source:American Cancer Society — What Is Lung Cancer?

Review status: AI-assisted, source checked. Not reviewed by a clinician. How we check pages

The short answer

The two main types of lung cancer are non-small cell lung cancer, which is the most common, and small cell lung cancer, which tends to grow and spread faster. The type guides treatment.

  • The two main types are non-small cell and small cell lung cancer.

  • Non-small cell lung cancer (NSCLC) is the most common, about 80% to 85% of cases.

  • Small cell lung cancer (SCLC) tends to grow and spread more quickly.

  • The two types are treated differently, so the type matters.

Choose how you want to read this

The whole article, with every detail and caution.

The simple version

This page is for people who have been told they have lung cancer, and their families. Lung cancer is grouped into two main types, based on how the cancer cells look under a microscope. Knowing the type matters, because the two are treated quite differently.

The two main types

Lung cancer falls into two groups:

  • Non-small cell lung cancer, or NSCLC — the most common type. It makes up about 80% to 85% of all lung cancers.
  • Small cell lung cancer, or SCLC — less common, at about 10% to 15% of cases. It tends to grow and spread faster.

Non-small cell lung cancer in more detail

NSCLC itself has several subtypes. Adenocarcinoma is the most common subtype overall. It is also the type most often found in people who have never smoked, as well as in women and younger patients. Squamous cell carcinoma and large cell carcinoma are the other main subtypes. All three share similar general treatment approaches. But the specific drugs used can differ based on the tumor's genetic features.

Small cell lung cancer in more detail

SCLC is strongly linked to smoking, more so than most NSCLC subtypes. It tends to grow quickly. It has often spread beyond the lungs by the time it is diagnosed. Despite this, it usually responds well at first to chemotherapy and radiation. The challenge is that it commonly returns after this initial response. This shapes how doctors plan long-term treatment and follow-up.

Why the type matters so much

NSCLC and SCLC are treated using different playbooks. SCLC responds well to chemotherapy and radiation. Those remain the backbone of treatment for most people. NSCLC treatment draws on a wider range of tools. These include surgery, radiation, targeted therapy, and immunotherapy. Doctors choose based on the cancer's stage and specific features.

Biomarker testing for non-small cell lung cancer

For NSCLC, doctors often test the tumor's genes and proteins. This is called biomarker testing. It can reveal specific changes, such as in the EGFR or ALK genes, that targeted drugs are built to attack. It can also reveal how much of a marker called PD-L1 the tumor carries. This helps predict whether immunotherapy is likely to help. Testing matches a specific drug to a specific tumor, instead of a one-size-fits-all approach.

More biomarkers than just EGFR and ALK

Doctors now test for several other gene changes too. Each one has a matching targeted drug:

  • KRAS: sotorasib
  • MET: capmatinib
  • RET: selpercatinib or pralsetinib
  • BRAF: dabrafenib combinations
  • ROS1: entrectinib
  • NTRK: larotrectinib

Not every tumor has one of these changes. Testing usually happens on tissue from the original biopsy (a sample of the tumor). Sometimes a blood test is added too.

What to ask your team

  • Which type of lung cancer do I have, and which subtype if it is non-small cell?
  • Has my tumor been tested for biomarkers like EGFR, ALK, or PD-L1?
  • How does the type affect my treatment options?
  • What does the type mean for my outlook?

Sources

A woman in a navy blazer and an older woman wearing a headscarf review a tablet together at a home or office table.

Common questions

What are the two main types?

Non-small cell lung cancer (NSCLC), the most common, and small cell lung cancer (SCLC), which is less common but tends to grow and spread faster.

How common is each?

About 80% to 85% of lung cancers are non-small cell. About 10% to 15% are small cell, which is strongly linked to smoking.

Why does the type matter?

The two types behave differently and are treated differently. Small cell lung cancer often responds to chemotherapy and radiation, while non-small cell may be treated with surgery, radiation, targeted therapy, or immunotherapy.

What is biomarker testing?

For non-small cell lung cancer, testing the tumor's genes can reveal changes that targeted therapies or immunotherapy can address, helping match treatment to the cancer.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Talk to a person

Talk with a trained specialist or navigator

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Prepared by Cancer Explained's AI-assisted editorial system

Written from American Cancer Society — What Is Lung Cancer? material and compared with the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Last updated: 2026-08-05Next planned review: 2027-07-07

Review details and limits

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

More on this topic

Words to know

Tap any term to see what it means.

Browse the full glossary →

Knowledge check

0 of 3 answered

  1. Q1.What are the two main types of lung cancer?
  2. Q2.Which type is most common?
  3. Q3.Which type tends to grow and spread faster?

This self-assessment checks understanding of educational content only. It is not medical advice.

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.